COVID-19 drug therapy options: An updateNo therapies have been proven effective for preventing or treating COVID-19; however, there are some promising options Canadian scientists at forefront of COVID-19 research and global responseSeveral Canadians are now involved in developing therapies to treat the novel coronavirus Biktarvy: new complete antiretroviral regimen for HIV Three-drug combination now available as a single-tablet once-daily regimen for treating HIV infection Truvada approved for pre-exposure prophylaxis of HIV-1 infection First antiretroviral indicated for reducing the risk of HIV infection in adults at high risk. Genvoya: new HIV single-tablet combo treatment similar to Stribild Contains new form of tenofovir that can be given in lower dose, with improved safety. Clinical Feature: HIV Pre-exposure prophylaxis (PrEP) An update for pharmacists on a new prevention strategy. Gilead opens innovative laboratory, pledges more investment in Alberta Health Canada warns of side effects from hepatitis C heart drug combo Department says people should not take Harvoni or Sovaldi in combination with amiodarone. Holkira Pak for chronic hepatitis C All-oral regimen provides three direct-acting antivirals with distinct mechanisms of action. Drug News: December 2014 A review of launches, new indications, Health Canada advisories and new dosage forms. First Previous 1 2 3 4 Next Last
